Jefferies Group Reiterates Hold Rating for BTG plc (BTG)
BTG plc (LON:BTG)‘s stock had its “hold” rating restated by analysts at Jefferies Group in a research report issued to clients and investors on Thursday. They currently have a GBX 525 ($8.80) price target on the stock. Jefferies Group’s target price suggests a potential downside of 12.93% from the company’s current price.
Shares of BTG plc (LON:BTG) traded up 0.24% on Thursday, hitting GBX 604.47. The stock had a trading volume of 434,651 shares. BTG plc has a 52 week low of GBX 353.10 and a 52 week high of GBX 624.00. The stock’s 50-day moving average is GBX 554.5 and its 200-day moving average is GBX 564.7.
Several other analysts have also recently commented on the stock. Analysts at FinnCap reiterated a “sell” rating on shares of BTG plc in a research note on Wednesday. They now have a GBX 345 ($5.78) price target on the stock. Separately, analysts at Nplus1 Brewin reiterated a “sell” rating on shares of BTG plc in a research note on Tuesday, May 27th. They now have a GBX 486 ($8.15) price target on the stock. Finally, analysts at Deutsche Bank reiterated a “buy” rating on shares of BTG plc in a research note on Friday, May 23rd. They now have a GBX 655 ($10.98) price target on the stock. Three analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of GBX 546.67 ($9.16).
BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.